{"name":"Crucell Holland BV","slug":"crucell-holland-bv","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":9,"colorKey":"immunology","drugs":[{"name":"Ad26.ZEBOV-Batch #1","genericName":"Ad26.ZEBOV-Batch #1","slug":"ad26-zebov-batch-1","indication":"Ebola virus disease prevention","status":"phase_3"},{"name":"Ad26.ZEBOV-Batch #2","genericName":"Ad26.ZEBOV-Batch #2","slug":"ad26-zebov-batch-2","indication":"Ebola virus disease prevention","status":"phase_3"},{"name":"Ad26.ZEBOV-Batch #3","genericName":"Ad26.ZEBOV-Batch #3","slug":"ad26-zebov-batch-3","indication":"Ebola virus disease prevention","status":"phase_3"},{"name":"Ad35.RSV.FA2","genericName":"Ad35.RSV.FA2","slug":"ad35-rsv-fa2","indication":"Other","status":"phase_1"},{"name":"Epaxal","genericName":"Epaxal","slug":"epaxal","indication":"Other","status":"phase_3"},{"name":"Epaxal 0.25 mL","genericName":"Epaxal 0.25 mL","slug":"epaxal-0-25-ml","indication":"Other","status":"phase_2"},{"name":"HRIG","genericName":"HRIG","slug":"hrig","indication":"Other","status":"phase_2"},{"name":"Inflexal V","genericName":"Inflexal V","slug":"inflexal-v","indication":"Other","status":"marketed"},{"name":"Quadrivalent virosomal influenza vaccine","genericName":"Quadrivalent virosomal influenza vaccine","slug":"quadrivalent-virosomal-influenza-vaccine","indication":"Other","status":"phase_1"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"oncology","drugs":[{"name":"CL184","genericName":"CL184","slug":"cl184","indication":"Unspecified infectious disease prevention","status":"phase_2"},{"name":"Engerix B","genericName":"Engerix B","slug":"engerix-b","indication":"Prevention of hepatitis B infection in infants, children, and adults","status":"marketed"},{"name":"Havrix 720","genericName":"Havrix 720","slug":"havrix-720","indication":"Prevention of hepatitis A infection in adults and children","status":"phase_3"},{"name":"HepavaxGene (thiomersal free)","genericName":"HepavaxGene (thiomersal free)","slug":"hepavaxgene-thiomersal-free","indication":"Hepatitis B prevention in infants, children, and adults","status":"phase_3"},{"name":"Quinvaxem in single dose vials","genericName":"Quinvaxem in single dose vials","slug":"quinvaxem-in-single-dose-vials","indication":"Prevention of invasive disease caused by Haemophilus influenzae type b","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"cardiovascular","drugs":[{"name":"HAVpur Junior","genericName":"HAVpur Junior","slug":"havpur-junior","indication":"Active immunization against hepatitis A in infants and children","status":"marketed"},{"name":"Quinvaxem in Uniject","genericName":"Quinvaxem in Uniject","slug":"quinvaxem-in-uniject","indication":"Primary immunization of infants and children against Haemophilus influenzae type b, diphtheria, tetanus, pertussis, and hepatitis B","status":"phase_3"},{"name":"Quinvaxem/Tritanrix","genericName":"Quinvaxem/Tritanrix","slug":"quinvaxem-tritanrix","indication":"Primary immunization against diphtheria, tetanus, pertussis, hepatitis B, and Haemophilus influenzae type b in infants and children","status":"marketed"}]}],"pipeline":[{"name":"CL184","genericName":"CL184","slug":"cl184","phase":"phase_2","mechanism":"CL184 is a vaccine that targets an unspecified pathogen.","indications":["Unspecified infectious disease prevention"],"catalyst":""},{"name":"Engerix B","genericName":"Engerix B","slug":"engerix-b","phase":"marketed","mechanism":"Engerix B is a recombinant hepatitis B vaccine that stimulates the immune system to produce antibodies against hepatitis B surface antigen (HBsAg).","indications":["Prevention of hepatitis B infection in infants, children, and adults","Post-exposure prophylaxis for hepatitis B"],"catalyst":""},{"name":"Ad26.ZEBOV-Batch #1","genericName":"Ad26.ZEBOV-Batch #1","slug":"ad26-zebov-batch-1","phase":"phase_3","mechanism":"Ad26.ZEBOV is a replication-incompetent adenovirus serotype 26 vector expressing the Ebola virus glycoprotein that primes the immune system to recognize and respond to Ebola virus infection.","indications":["Ebola virus disease prevention"],"catalyst":""},{"name":"Ad26.ZEBOV-Batch #2","genericName":"Ad26.ZEBOV-Batch #2","slug":"ad26-zebov-batch-2","phase":"phase_3","mechanism":"Ad26.ZEBOV is a replication-incompetent adenovirus serotype 26 vector expressing the Ebola virus glycoprotein that primes the immune system to recognize and respond to Ebola virus infection.","indications":["Ebola virus disease prevention"],"catalyst":""},{"name":"Ad26.ZEBOV-Batch #3","genericName":"Ad26.ZEBOV-Batch #3","slug":"ad26-zebov-batch-3","phase":"phase_3","mechanism":"Ad26.ZEBOV is a replication-incompetent adenovirus serotype 26 vector expressing the Ebola virus glycoprotein, designed to elicit immune responses against Ebola virus.","indications":["Ebola virus disease prevention"],"catalyst":""},{"name":"Ad35.RSV.FA2","genericName":"Ad35.RSV.FA2","slug":"ad35-rsv-fa2","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Epaxal","genericName":"Epaxal","slug":"epaxal","phase":"phase_3","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Epaxal 0.25 mL","genericName":"Epaxal 0.25 mL","slug":"epaxal-0-25-ml","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"HAVpur Junior","genericName":"HAVpur Junior","slug":"havpur-junior","phase":"marketed","mechanism":"HAVpur Junior is an inactivated hepatitis A vaccine that stimulates the immune system to produce antibodies against hepatitis A virus.","indications":["Active immunization against hepatitis A in infants and children"],"catalyst":""},{"name":"HRIG","genericName":"HRIG","slug":"hrig","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Havrix 720","genericName":"Havrix 720","slug":"havrix-720","phase":"phase_3","mechanism":"Havrix 720 is an inactivated hepatitis A vaccine that stimulates the immune system to produce antibodies against hepatitis A virus.","indications":["Prevention of hepatitis A infection in adults and children"],"catalyst":""},{"name":"HepavaxGene (thiomersal free)","genericName":"HepavaxGene (thiomersal free)","slug":"hepavaxgene-thiomersal-free","phase":"phase_3","mechanism":"HepavaxGene is a recombinant hepatitis B vaccine that stimulates the immune system to produce antibodies against hepatitis B surface antigen.","indications":["Hepatitis B prevention in infants, children, and adults"],"catalyst":""},{"name":"Inflexal V","genericName":"Inflexal V","slug":"inflexal-v","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Quadrivalent virosomal influenza vaccine","genericName":"Quadrivalent virosomal influenza vaccine","slug":"quadrivalent-virosomal-influenza-vaccine","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Quinvaxem in Uniject","genericName":"Quinvaxem in Uniject","slug":"quinvaxem-in-uniject","phase":"phase_3","mechanism":"Quinvaxem is a pentavalent conjugate vaccine that provides immunization against Haemophilus influenzae type b, diphtheria, tetanus, pertussis, and hepatitis B through stimulation of humoral and cellular immune responses.","indications":["Primary immunization of infants and children against Haemophilus influenzae type b, diphtheria, tetanus, pertussis, and hepatitis B"],"catalyst":""},{"name":"Quinvaxem in single dose vials","genericName":"Quinvaxem in single dose vials","slug":"quinvaxem-in-single-dose-vials","phase":"phase_3","mechanism":"Quinvaxem is a pentavalent conjugate vaccine that provides immunization against five bacterial pathogens by stimulating antibody and cellular immune responses.","indications":["Prevention of invasive disease caused by Haemophilus influenzae type b","Prevention of meningococcal disease (serogroups A and C)","Prevention of pneumococcal disease","Prevention of cholera"],"catalyst":""},{"name":"Quinvaxem/Tritanrix","genericName":"Quinvaxem/Tritanrix","slug":"quinvaxem-tritanrix","phase":"marketed","mechanism":"Quinvaxem/Tritanrix is a combination vaccine that stimulates the immune system to produce antibodies against diphtheria, tetanus, pertussis, hepatitis B, and Haemophilus influenzae type b.","indications":["Primary immunization against diphtheria, tetanus, pertussis, hepatitis B, and Haemophilus influenzae type b in infants and children"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOUDk3dmtjeGRWT3h5dkF6dWNhREpLVS1OZWZrS1p0S2M2NE1FZEJNQ0t5T0prc3djNlV1bVR4VTUxYWRtaGFOaHpFVy1DMlFJdUVCazc0ckdlRjhRYXJCR3k4NzZZWHpwMmVObmRoajZzWklCRG93RGx5YnNFNEhWTkh6RThFQnoxTXhzWlB1UzFJdnZuS1RvTXFwY21QRm5hM0ZiU0RvUVhIdHp2U1FMMEdB?oc=5","date":"2022-01-18","type":"deal","source":"drugdiscoverytrends.com","summary":"Leyden Labs licenses monoclonal antibody for influenza A and B from Janssen - drugdiscoverytrends.com","headline":"Leyden Labs licenses monoclonal antibody for influenza A and B from Janssen","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxOelVjWEFFSUNuVTVZYzVheVMzY3NrYl9tTXBza3BXQ1RaQmRZODhoeEJZdWNDYVo3b1VjdDJmd0tyNkFQS0o1S19CRjRMbUFwc01od2JiS1hBSE5ocjZhM0hvRTE2WGZSVzBRRHExZkVTOUg4X3FwWm1FS3U1S3Bra1JzYjh2YXhOM2cwdg?oc=5","date":"2020-04-03","type":"pipeline","source":"Scripps Research","summary":"Clues to COVID-19 coronavirus’s vulnerability emerge from an antibody against SARS - Scripps Research","headline":"Clues to COVID-19 coronavirus’s vulnerability emerge from an antibody against SARS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPOTZIanJHdXk3SkR4dUFCRmI3QjdWMjlxWnpqWWllcWI4THlOMzM1THJTNUxMcWI5Z3JlbF9mdlVZWXZQbmdNNDVaaldfVGl0NHlKTGVoQXhFUzBMN1YxM2gwQ2xuSGI2cWN6ay1OMElDOTZoREhsTjdLeXM2Qmpob1VKQUdkOHV3a1RIa0MwU3o1Y0l2LVhkUnNR?oc=5","date":"2020-01-14","type":"pipeline","source":"SwitSalone","summary":"First ebola ‘EBOVAC-Salone’ vaccines given out in Sierra Leone - SwitSalone","headline":"First ebola ‘EBOVAC-Salone’ vaccines given out in Sierra Leone","sentiment":"neutral"}],"patents":[],"drugCount":17,"phaseCounts":{"phase_2":3,"marketed":4,"phase_3":8,"phase_1":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}